Thoracic Oncology and Chest Procedures Network
-
Lung cancer survivorship: Life beyond diagnosis, treatment, and rechecks
It is no longer enough to “survive” lung cancer; our responsibility as pulmonologists is to help survivors persevere beyond it.
-
Definitions matter: How should we define diagnostic yield in bronchoscopy?
A recent consensus statement from CHEST and the American Thoracic Society proposes a strict diagnostic yield definition, reiterating the need for close follow-up in patients with nonspecific benign findings.
-
Making it stick: Rapid pleurodesis for MPE offers faster freedom from IPCs
Rapid pleurodesis combines prompt symptom control with the potential for pleural symphysis in a shorter time frame, allowing for potential lifestyle benefits while minimizing the risk of IPC-related complications.
-
Revolutionizing respiratory care: Bedside ultrasound for diaphragm assessment
Diaphragm ultrasound is a safe, noninvasive tool that evaluates respiratory muscle function, aiding in diagnosis, weaning from ventilation, and management of lung disease.
-
EBUS nodal staging in early-stage non-small cell lung cancer
EBUS-TBNA disrupted the field of bronchoscopy by offering a minimally invasive, real-time imaging approach to biopsy, but recent data have emerged that show routine use of EBUS may warrant scrutiny.
-
In our navigational bronchoscopy ERA
The VERITAS trial is a turning point for interventional pulmonology, ushering in an era of high-quality comparative effectiveness trials poised to transform our approach to technology evaluation, implementation, and, ultimately, patient care.
-
Opening the flood gates: Pleural complications of immune checkpoint inhibitors
The pulmonary and medical oncology community must start to consider pleural complications as a potential risk of immune checkpoint inhibitor therapy.
-
POCUS for temporary intracorporeal and extracorporeal mechanical circulatory support
POCUS use refines diagnostic accuracy, enhances procedural safety, and optimizes outcomes for patients requiring advanced circulatory support.
-
Artificial intelligence in lung cancer management
As artificial intelligence continues to integrate into clinical practice, the future of lung cancer management is shifting toward precision-driven, data-informed strategies and risk prediction models.
-
Managing central airway obstruction
New guidelines on central airway obstruction standardize diagnosis and management recommendations, emphasizing therapeutic bronchoscopy, rigid bronchoscopy, and multidisciplinary care.
